Market Research Report

RNAi Therapy Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-11723
  • CAT ID : 7
  • Pages : 92
  • Date : Jun 2023
 

The global RNAi Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Small Molecule Interfering Ribonucleic Acid (SiRNA) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of RNAi Therapy include Alnylam, Sarepta Therapeutics, Alnylam Pharmaceuticals, Moderna, Sanofi, Arcturus Therapeutics, Silence and Sirnaomics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for RNAi Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Therapy. This report contains market size and forecasts of RNAi Therapy in global, including the following market information:
Global RNAi Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the RNAi Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNAi Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global RNAi Therapy Market Segment Percentages, by Type, 2022 (%)
Small Molecule Interfering Ribonucleic Acid (SiRNA)
Microrna (MiRNA)
Global RNAi Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global RNAi Therapy Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiology
Others
Global RNAi Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global RNAi Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNAi Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies RNAi Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam
Sarepta Therapeutics
Alnylam Pharmaceuticals
Moderna
Sanofi
Arcturus Therapeutics
Silence
Sirnaomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNAi Therapy, market overview.
Chapter 2: Global RNAi Therapy market size in revenue.
Chapter 3: Detailed analysis of RNAi Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNAi Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 RNAi Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNAi Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNAi Therapy Overall Market Size
2.1 Global RNAi Therapy Market Size: 2022 VS 2029
2.2 Global RNAi Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNAi Therapy Players in Global Market
3.2 Top Global RNAi Therapy Companies Ranked by Revenue
3.3 Global RNAi Therapy Revenue by Companies
3.4 Top 3 and Top 5 RNAi Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies RNAi Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNAi Therapy Players in Global Market
3.6.1 List of Global Tier 1 RNAi Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 RNAi Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global RNAi Therapy Market Size Markets, 2022 & 2029
4.1.2 Small Molecule Interfering Ribonucleic Acid (SiRNA)
4.1.3 Microrna (MiRNA)
4.2 By Type - Global RNAi Therapy Revenue & Forecasts
4.2.1 By Type - Global RNAi Therapy Revenue, 2018-2023
4.2.2 By Type - Global RNAi Therapy Revenue, 2024-2029
4.2.3 By Type - Global RNAi Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNAi Therapy Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Others
5.2 By Application - Global RNAi Therapy Revenue & Forecasts
5.2.1 By Application - Global RNAi Therapy Revenue, 2018-2023
5.2.2 By Application - Global RNAi Therapy Revenue, 2024-2029
5.2.3 By Application - Global RNAi Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global RNAi Therapy Market Size, 2022 & 2029
6.2 By Region - Global RNAi Therapy Revenue & Forecasts
6.2.1 By Region - Global RNAi Therapy Revenue, 2018-2023
6.2.2 By Region - Global RNAi Therapy Revenue, 2024-2029
6.2.3 By Region - Global RNAi Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America RNAi Therapy Revenue, 2018-2029
6.3.2 US RNAi Therapy Market Size, 2018-2029
6.3.3 Canada RNAi Therapy Market Size, 2018-2029
6.3.4 Mexico RNAi Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe RNAi Therapy Revenue, 2018-2029
6.4.2 Germany RNAi Therapy Market Size, 2018-2029
6.4.3 France RNAi Therapy Market Size, 2018-2029
6.4.4 U.K. RNAi Therapy Market Size, 2018-2029
6.4.5 Italy RNAi Therapy Market Size, 2018-2029
6.4.6 Russia RNAi Therapy Market Size, 2018-2029
6.4.7 Nordic Countries RNAi Therapy Market Size, 2018-2029
6.4.8 Benelux RNAi Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia RNAi Therapy Revenue, 2018-2029
6.5.2 China RNAi Therapy Market Size, 2018-2029
6.5.3 Japan RNAi Therapy Market Size, 2018-2029
6.5.4 South Korea RNAi Therapy Market Size, 2018-2029
6.5.5 Southeast Asia RNAi Therapy Market Size, 2018-2029
6.5.6 India RNAi Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America RNAi Therapy Revenue, 2018-2029
6.6.2 Brazil RNAi Therapy Market Size, 2018-2029
6.6.3 Argentina RNAi Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNAi Therapy Revenue, 2018-2029
6.7.2 Turkey RNAi Therapy Market Size, 2018-2029
6.7.3 Israel RNAi Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia RNAi Therapy Market Size, 2018-2029
6.7.5 UAE RNAi Therapy Market Size, 2018-2029
7 RNAi Therapy Companies Profiles
7.1 Alnylam
7.1.1 Alnylam Company Summary
7.1.2 Alnylam Business Overview
7.1.3 Alnylam RNAi Therapy Major Product Offerings
7.1.4 Alnylam RNAi Therapy Revenue in Global Market (2018-2023)
7.1.5 Alnylam Key News & Latest Developments
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Company Summary
7.2.2 Sarepta Therapeutics Business Overview
7.2.3 Sarepta Therapeutics RNAi Therapy Major Product Offerings
7.2.4 Sarepta Therapeutics RNAi Therapy Revenue in Global Market (2018-2023)
7.2.5 Sarepta Therapeutics Key News & Latest Developments
7.3 Alnylam Pharmaceuticals
7.3.1 Alnylam Pharmaceuticals Company Summary
7.3.2 Alnylam Pharmaceuticals Business Overview
7.3.3 Alnylam Pharmaceuticals RNAi Therapy Major Product Offerings
7.3.4 Alnylam Pharmaceuticals RNAi Therapy Revenue in Global Market (2018-2023)
7.3.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.4 Moderna
7.4.1 Moderna Company Summary
7.4.2 Moderna Business Overview
7.4.3 Moderna RNAi Therapy Major Product Offerings
7.4.4 Moderna RNAi Therapy Revenue in Global Market (2018-2023)
7.4.5 Moderna Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi RNAi Therapy Major Product Offerings
7.5.4 Sanofi RNAi Therapy Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Arcturus Therapeutics
7.6.1 Arcturus Therapeutics Company Summary
7.6.2 Arcturus Therapeutics Business Overview
7.6.3 Arcturus Therapeutics RNAi Therapy Major Product Offerings
7.6.4 Arcturus Therapeutics RNAi Therapy Revenue in Global Market (2018-2023)
7.6.5 Arcturus Therapeutics Key News & Latest Developments
7.7 Silence
7.7.1 Silence Company Summary
7.7.2 Silence Business Overview
7.7.3 Silence RNAi Therapy Major Product Offerings
7.7.4 Silence RNAi Therapy Revenue in Global Market (2018-2023)
7.7.5 Silence Key News & Latest Developments
7.8 Sirnaomics
7.8.1 Sirnaomics Company Summary
7.8.2 Sirnaomics Business Overview
7.8.3 Sirnaomics RNAi Therapy Major Product Offerings
7.8.4 Sirnaomics RNAi Therapy Revenue in Global Market (2018-2023)
7.8.5 Sirnaomics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe